For citations:
Krysanova V.S., Ermolaeva E.D., Ermolaeva T.N., Davydovskaya M.V., Kokushkin K.A. ECONOMIC ASPECTS OF APPLICATION OF THE RUSSIAN BIOSIMILAR OMALIZUMAB IN PATIENTS WITH ATOPIC BRONCHIAL ASTHMA OF MODERATE TO SEVERE CLINICAL COURSES. Pharmacy & Pharmacology. 2021;9(3):235-248. https://doi.org/10.19163/2307-9266-2021-9-3-235-248